Sheng Li Xue Bao (Acta Physiologica Sinica). Vol. 67, no. 1. (February 25, 2015): 1–18.
91. Pearson KJ, Lewis KN, Price NL, Chang JW, Perez E, Cascajo MV, Tamashiro KL, Poosala S, Csiszar A, Ungvari Z, Kensler TW, Yamamoto M, Egan JM, Longo DL, Ingram DK, Navas P, de Cabo R. “Nrf2 Mediates Cancer Protection but Not Prolongevity Induced by Caloric Restriction.” Proceedings of the National Academy of Sciences of the United States of America. Vol. 105, no. 7. (2008): 2325–2330.
92. Bishop NA, Guarente L. “Two Neurons Mediate Diet-Restriction-Induced Longevity in C. Elegans.” Nature. Vol. 447, no. 7144. (2007): 545–549.
93. Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D. “The Role of the Antioxidant and Longevity-Promoting Nrf2 Pathway in Metabolic Regulation.” Current Opinions in Clinical Nutrition and Metabolic Care. Vol. 14, no. 1. (January 2011): 41–48.
94. Martín-Montalvo A, Villalba JM, Navas P, de Cabo R. “NRF2, Cancer and Calorie Restriction.” Oncogene. Vol. 30, no. 5. (February 3, 2011): 505–520.
95. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R. “Mechanisms Underlying Caloric Restriction and Lifespan Regulation: Implications for Vascular Aging.” Circulation Research. Vol. 102, no. 5. (March 14, 2008): 519–528.
96. Lei P, Tian S, Teng C, Huang L, Liu X, Wang J, Zhang Y, Li B, Shan Y. “Sulforaphane Improves Lipid Metabolism by Enhancing Mitochondrial Function and Biogenesis in Vivo and In Vitro.” Molecular Nutrition & Food Research. Vol. 63, no. 4. (February 2019): e1800795. doi: 10.1002/mnfr.201800795.
97. Huang DD, et al. “Nrf2 Deficiency Exacerbates Frailty and Sarcopenia by Impairing Skeletal Muscle Mitochondrial Biogenesis and Dynamics in an Age-Dependent Manner.” Experimental Gerontology. Vol. 119. (January 25, 2019): 617–623. doi: 10.1016/j.exger.2019.01.022.
98. Piechota-Polanczyk A, Kopacz A, Kloska D, Zgrapan B, Neumayer C, GrochotPrzeczek A, Huk I, Brostjan C, Dulak J, Jozkowicz A.“Simvastatin Treatment Upregulates HO-1 in Patients with Abdominal Aortic Aneurysm but Independently of Nrf2.” Oxidative Medicine and Cellular Longevity. Vol. 2018, no. 28. (March 2018.) doi: 10.1155/2018/2028936.
99. Smith RE, Tran K, Smith CC, McDonald M, Shejwalkar P, Hara K“ The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases.” Oxidative Medicine and Cellular Longevity. Vol. 4, no. 4. (December 2016): 34.
100. Jang HJ, Hong EM, Kim M, Kim JH, Jang J, Park SW, Byun HW, Koh DH, Choi MH, Kae SH, Lee J. “Simvastatin Induces Heme Oxygenase-1 via NF-E2-Related Factor 2 (Nrf2) Activation through ERK and PI3K/Akt Pathway in Colon Cancer.” Oncotarget. Vol. 7, no. 29. (July 19, 2016): 46219–46229. doi: 10.18632/oncotarget.10078.
101. Leonardo CC, Doré S. “Dietary Flavonoids Are Neuroprotective through Nrf2-Coordinated Induction of Endogenous Cytoprotective Proteins.” Nutritional Neuroscience. Vol. 14, no. 5. (September 2011): 226–236. doi: 10.1179/1476830511Y.0000000013.
102. Kumar H, Kim IS, More SV, Kim BW, Choi DK. “Natural Product-Derived Pharmacological Modulators of Nrf2/ARE Pathway for Chronic Disease.” Natural Products Reports. Vol. 31, no. 1. (January 2014): 109–139.
103. Baird L, Dinkova-Kostova AT. “The Cytoprotective Role of the Keap1-Nrf2 Pat hway.” Archives of Toxicology. Vol. 85, no. 4. (April 2011): 241–272.
104. Gao B, Doan A, Hybertson BM. “The Clinical Potential of Nrf2 Signaling in Degenerative and Immunological Disorders.” Journal of Clinical Pharmacology. Vol. 6. (2014): 19–34.
105. Sandberg M, Patil J, D’Angelo B, Weber SG, Mallard C. “NRF2-Regulation in Brain Health and Disease: Implication of Cerebral Inflammation.” Neuropharmacology. Vol. 79. (2014): 298–306. doi: 10.1016/j.neuropharm.2013.11.004.
106. Seo HA, Lee IK. “The Role of Nrf2: Adipocyte Differentiation, Obesity, and Insulin Resistance.” Oxidative Medicine and Cellular Longevity. Vol. 2013. (2013): 184598.
107. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr., Mafra D. “Nrf2-keap1 System Versus NF-κB: The Good and the Evil in Chronic Kidney Disease?” Biochimie. Vol. 94, no. 12. (December 2012): 2461–2466. doi: 10.1016/j.biochi.2012.07.015.
108. Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang CX, Saw CL, Khor TO, Kong AN, Reuhl K, Lee MJ, Yang CS, SUh N. “Dietary Tocopherols Inhibit Cell Proliferation, Regulate Expression of ERα, PPARγ, and Nrf2, and Decrease Serum Inflammatory Markers During the Development of Mammary Hyperplasia.” Molecular Carcinogenesis. Vol. 52. (2013): 514–525. doi: 10.1002/mc.21886.
109. Chen L, Yang R, Qiao W, Zhang W, Chen J, Mao L, Goltzman D, Miao D. “1,25-Dihydroxyvitamin D Exerts an Antiaging Role by Activation of Nrf2-Antioxidant Signaling and Inactivation of p16/p53-Senescence Signaling.” Aging Cell. Vol. 18. (March 24, 2019): e 12951. doi: 10.1111/acel.12951.
110. Chen H, Xie K, Han H, Li Y, Liu L, Yang T, Yu Y. “Molecular Hydrogen Protects Mice Against Polymicrobial Sepsis by Ameliorating Endothelial Dysfunction via an Nrf2/HO-1 Signaling Pathway.” International Immunopharmacology. Vol. 28, no. 1. (September 2015): 643–654.
111. Yu J, Zhang W, Zhang R, Jiang G, Tang H, Ruan X, Ren P, Lu B. “Molecular Hydrogen Attenuates Hypoxia/Reoxygenation Injury of Intrahepatic Cholangiocytes by Activating Nrf2 Expression.” Toxicology Letters. Vol. 238, no. 3. (November 4, 2015): 11–19. doi: 10.1016/j.toxlet.2015.08.010.
112. Kawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K, Tanaka Y, Noda K, Peng X, Takahashi T, Billiar TR, Okumura M, Toyoda Y, Kensler TW, Nakao A. “Hydrogen Gas Reduces Hyperoxic Lung Injury via the Nrf2 Pathway in Vivo.” American Journal of Physiology-Lung Cellular and Molecular Physiology. Vol. 304, no. 10. (May 15, 2013): L646–L656. doi: 10.1152/ajplung.00164.2012.
113. Huang C, Wu J, Chen D, Jin J, Wu Y, Chen Z. “Effects of Sulforaphane in the Central Nervous System.” European Journal of Pharmacology. Vol. 853. (June 15, 2019): 153–168. doi: 10.1016/j.ejphar.2019.03.010.
114. Singh S, Dubey V, Meena A, Siddiqui L, Maruya AK, Luqman S. “Rutin Restricts Hydrogen Peroxide-Induced Alterations by Up-Regulating the Redox-System: An in Vitro, in Vivo and in Silico Study.” European Journal of Pharmacology. Vol. 835. (July 31, 2018): 115–125. doi: 10.1016/j.ejphar.2018.07.055.
115. Tian R. “Rutin Ameliorates Diabetic Neuropathy by Lowering Plasma Glucose and Decreasing Oxidative Stress via Nrf2 Signaling Pathway in Rats.” European Journal of Pharmacology. Vol. 771. (January 15, 2016): 84–92. doi: 10.1016/j.ejphar.2015.12.021.
116. Chaiprasongsuk A, Onkoksoong T, Pluemsamran T, Limsaengurai S, Panich U. “Photoprotection by Dietary Phenolics against Melanogenesis through Nrf2-Dependent Antioxidant Responses.” Redox Biology. Vol. 8. (August 2016): 79–90. doi: 10.1016/j.redox.2015.12.006.
117. Lee YJ, Lee DM, Lee SH. “Nrf2 Expression and Apoptosis in Quercetin-Treated Malignant Mesothelioma Cells” Molecules and Cells. Vol. 38, no. 5. (May 31, 2015): 416–425. doi: 10.14348/molcells.2015.2268.
118. Sun GY, Chen Z, Jasmer KJ, Chuang DY, Gu Z, Hannink M, Simonyi A. “Quercetin Attenuates Inflammatory Responses in BV-2 Microglial Cells: Role of MAPKs on the Nrf2 Pathway and Induction of Heme Oxygenase-1.” PLoS One. Vol. 10, no. 10. (October 27, 2015): e0141509. doi: 10.1371/journal.pone.0141509.
119. Jin Y, Huang ZL, Li L, Yang Y, Wang CH, Wang ZT, Ji LL. “Quercetin Attenuates Toosendanin-Induced Hepatotoxicity through Inducing the Nrf2/GCL/GSH Antioxidant Signaling Pathway.” Acta Pharmacologica Sinica. Vol. 40, no. 1. (January 2019): 75–85. doi: 10.1038/s41401-018-0024-8.
120. Miltonprabu S, Tomczyk M, Skalicka-Wózniak K, Rastrelli L, Daglia M, Nabavi SF, Alavian SM, Nabavi SM. “Hepatoprotective Effect of Quercetin: From Chemistry to Medicine.” Food and Chemical Toxicology. Vol. 108, Part B. (October 2017): 365–374. doi: 10.1016/j.fct.2016.08.034.
121. Iranshahy M, Iranshsahi M, Abtahi SR, Karimi G. “The Role of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatoprotective Activity of Natural Products: A Review.” Food and Chemical Toxicology. Vol. 120. (October 2018): 261–276. doi: 10.1016/j.fct.2018.07.024.
122. Lu C, Zhang F, Xu W, Wu X, Lian N, Jin H, Chen Q, Chen L, Shao J, Wu L, Lu Y, Zheng S. “Curcumin Attenuates Ethanol-Induced Hepatic Steatosis through Modulating Nrf2/FXR Signaling in Hepatocytes.” IUBMB Life. Vol. 67, no. 8. (August 2015 Aug): 645–58. doi: 10.1002/iub.1409.
123. Chen B, Zhang Y, Wang Y, Rao J, Jiang X, Xu Z. “Curcumin Inhibits Proliferation of Breast Cancer Cells through Nrf2-Mediated Down-Regulation of Fen1 Expression.” Journal of Steroid Biochemistry and Molecular Biology. Vol. 143. (September 2014): 11–18. doi: 10.1016/j.jsbmb.2014.01.009.
124. Zhang H, Zheng W, Feng X, Yang F, Qin H, Wu S, Hou DX, Chen J. “Nrf2–ARE Signaling Acts as Master Pathway for the Cellular Antioxidant Activity of Fiseti n.” Molecules. Vol. 24, no. 4. (2018): 708. doi: 10.3390/molecules24040708.
125. Elshaer M, Chen Y, Wang XJ, Tang X. “Resveratrol: An Overview of Its Anti-Cancer Mechanisms.” Life Sciences. Vol. 207. (August 15, 2018): 340–349. doi: 10.1016/j.lfs.2018.06.028.
126. Cheng L, Jin Z, Zhao R, Ren K, Deng C, Yu S. “Resveratrol Attenuates Inflammation and Oxidative Stress Induced by Myocardial Ischemia-Reperfusion Injury: Role of Nrf2/ARE Pathway.” International Journal of Clinical and Experimental Medicine. Vol. 8, no. 7. (2015): 10420–10428.
127. Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK. “Resveratrol Inhibits Estrogen-Induced Breast Carcinogenesis through Induction of NRF2-Mediated Protective Pathways.”